1) Human PML-Ⅲprotein
人PML-3
2) Ad-PML construction
Ad-PML构建
3) PML gene
PML基因
1.
Objective:To construct the recombinant adenovirus plasmid carring human PML gene for further study.
将质粒PSG-PML与含有5型腺病毒右臂的质粒pPE3共转染至293细胞,产生含PML基因的重组腺病毒(Ad-pml),并经PCR及DNA测序鉴定。
4) PML-RARα gene
PML-RARα基因
1.
Aim: To construct a eukaryotic coexpression plasmid containing PML-RARα gene and human GM-CSF(hGM-CSF) gene,which was expected to be used as a modified DNA vaccine for acute promyelocytic leukemia.
目的:构建急性早幼粒细胞白血病(APL)PML-RARα基因与人粒巨噬细胞集落刺激因子(hGM-CSF)基因真核双表达载体,为利用DNA疫苗治疗APL奠定基础。
2.
Objective To construct the PML-RARα gene recombinant plasmid, which is expected to be used as a modified DNA vaccine for acute promyelocytic leukemia.
目的构建PML-RARα基因重组表达质粒,为发展PML-RARα基因疫苗提供实验依据。
5) PML-RARα peptide
PML-RARα多肽
1.
Objective To investigate the specific cytotoxicity of T cells from cord blood induced by PML-RARα peptide and NB4 cells in vitro.
目的了解PML-RARα多肽和NB4细胞体外诱导体外诱导增殖的T细胞的特异性细胞毒作用。
6) PML/RARα isoform
PML/RARα异型
1.
To evaluate the relation of PML/RARα isoforms in adult APL patients to clinical therapy and prognosis, the picture of blood and bone marrow aspirates for 71 APL patients treated by induction therapy were peridically examined and the different transcripts of PML/RARα were assayed by nested RT-PCR.
为评价急性早幼粒细胞白血病(APL)PML/RARα异型与临床治疗及预后的相关性,对71例诱导治疗的APL患者定期进行血像、骨髓像检查,用巢式RT-PCR检测PML/RARα不同转录本。
补充资料：构建
建立（多用于抽象事物）：～新的学科体系。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条